Results 11 to 20 of about 760,426 (217)

Hepatic encephalopathy

open access: yesNature Reviews Disease Primers, 2022
Hepatic encephalopathy (HE) is a prognostically relevant neuropsychiatric syndrome that occurs in the course of acute or chronic liver disease. Besides ascites and variceal bleeding, it is the most serious complication of decompensated liver cirrhosis.
Dieter Häussinger   +11 more
openaire   +11 more sources

Autoimmune Hepatitis [PDF]

open access: yesNature Reviews Gastroenterology & Hepatology, 1996
Autoimmune hepatitis is an inflammatory liver disease in which the immune system is believed to orchestrate an immune attack onto the liver cell. Current knowledge suggests that both T helper 1 (TH1) and TH2 programmes are involved in the generation of the liver damage.
Vergani, D, Mieli-Vergani, G
openaire   +12 more sources

Hepatitis A, Italy [PDF]

open access: yesEmerging Infectious Diseases, 2005
To the Editor: Hepatitis A virus (HAV) infection rates are very low in industrialized countries. A noticeable fall in the prevalence of HAV antibodies (anti-HAV) has been reported in southern European and Mediterranean countries such as Spain (1) and Greece (2), reflecting improvements in hygiene standards in the last decades.
D'AMELIO, Raffaele   +7 more
openaire   +6 more sources

Hepatitis [PDF]

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2001
Worldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV) and another 350 million individuals are chronically infected with hepatitis B virus (HBV) (1,2). Canada is estimated to have 240,000 to 300,000 HCV and 200,000 to 280,000 HBV chronic carriers (3,4).
openaire   +3 more sources

Hepatitis C and hepatic steatosis [PDF]

open access: yesQJM, 2010
Hepatic steatosis is commonly seen in patients with chronic hepatitis C infection, and the two together have a greater association than by chance alone. Hepatitis C virus is closely associated with lipid metabolism throughout its lifecycle. Hepatic steatosis is more common in genotype 3 infection, due to direct viral effects including through ...
Simon D. Taylor-Robinson   +3 more
openaire   +3 more sources

Hepatitis A: The changing epidemiology of hepatitis A [PDF]

open access: yesClinical Liver Disease, 2013
Hepatitis A is a communicable disease of the liver caused by hepatitis A virus (HAV), which is a single-stranded, linear, nonenveloped RNA virus of the Picornaviridae family. The incubation period is 14 to 28 days (up to 50 days). The diagnosis is made with a positive test for immunoglobulin M antibody to hepatitis A virus (anti-HAV), which is ...
Trudy V. Murphy, Noele P. Nelson
openaire   +3 more sources

Identification of recent cases of hepatitis C virus infection using physical-chemical properties of hypervariable region 1 and a radial basis function neural network classifier

open access: yesBMC Genomics, 2017
Background Identification of acute or recent hepatitis C virus (HCV) infections is important for detecting outbreaks and devising timely public health interventions for interruption of transmission.
James Lara, Mahder Teka, Yury Khudyakov
doaj   +1 more source

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognos- tic factor in hepatitis C virus-related hepatocellular carcinoma [PDF]

open access: yesClinical and Molecular Hepatology, 2021
Background/Aims Growth hormone (GH) is the main regulator of somatic growth, metabolism, and gender dimorphism in the liver. GH receptor (GHR) signaling in cancer is derived from a large body of evidence, although the GHR signaling pathway involved in ...
Ching-Chih Lin   +9 more
doaj   +1 more source

Hepatic Venography in Hepatic Tumors

open access: yesThe Tohoku Journal of Experimental Medicine, 1969
In order to establish the diagnosis of hepatic tumors, hepatic venography was performed in 9 cases of primary hepatic tumors and in 17 cases of metastatic hepatic tumors. The deformity of the hepatic veins due to compression by tumors was observed in 42 per cent of the cases.
H. Iida   +4 more
openaire   +4 more sources

Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery

open access: yesHarm Reduction Journal, 2023
Background The World Health Organization (WHO) recommends oral pre-exposure prophylaxis (PrEP) for all people at substantial risk of HIV as part of combination prevention.
Graham Shaw   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy